| Literature DB >> 29498430 |
Florien M Kruse1, Niek W Stadhouders1, Eddy M Adang2, Stef Groenewoud3, Patrick P T Jeurissen1,4.
Abstract
European countries have enhanced the scope of private provision within their health care systems. Privatizing services have been suggested as a means to improve access, quality, and efficiency in health care. This raises questions about the relative performance of private hospitals compared with public hospitals. Most systematic reviews that scrutinize the performance of the private hospitals originate from the United States. A systematic overview for Europe is nonexisting. We fill this gap with a systematic realist review comparing the performance of public hospitals to private hospitals on efficiency, accessibility, and quality of care in the European Union. This review synthesizes evidence from Italy, Germany, the United Kingdom, France, Greece, Austria, Spain, and Portugal. Most evidence suggests that public hospitals are at least as efficient as or are more efficient than private hospitals. Accessibility to broader populations is often a matter of concern in private provision: Patients with higher social-economic backgrounds hold better access to private hospital provision, especially in private parallel systems such as the United Kingdom and Greece. The existing evidence on quality of care is often too diverse to make a conclusive statement. In conclusion, the growth in private hospital provision seems not related to improvements in performance in Europe. Our evidence further suggests that the private (for-profit) hospital sector seems to react more strongly to (financial) incentives than other provider types. In such cases, policymakers either should very carefully develop adequate incentive structures or be hesitant to accommodate the growth of the private hospital sector.Entities:
Keywords: efficiency; health care quality; health services accessibility; literature review; private sector
Mesh:
Year: 2018 PMID: 29498430 PMCID: PMC6033142 DOI: 10.1002/hpm.2502
Source DB: PubMed Journal: Int J Health Plann Manage ISSN: 0749-6753
Search terms in abstract, keywords, and title (simplified)
|
|
|
|
|
|
|
|
Search string
| Scopus | |
|---|---|
| Before 2008 | |
|
| |
| After 2008 | |
|
| |
| And no keywords “Medicare” | |
| Limit to Journal, Article, English | |
| Search string: EconLit & SocINDEX | |
|
Search terms (AB “private w/2 hospital” OR AB (privatization AND hospital |
Search Options |
| Search string: Web of Science | |
|
TS = “private hospital” OR | Indexes = SCI‐EXPANDED, SSCI, A&HCI, ESCI Timespan = 2000‐2017 |
Figure 1Flow chart of selection process
Inclusion criteria for the second phase
| Population | Private hospitals; this could be a nonprofit or for‐profit hospital. Papers that include private hospitals as a control variable are also considered to be eligible. |
| Intervention/exposure | Patients are exposed to the service delivery of private hospitals. |
| Comparison | A comparison should be made with public hospitals. |
| Outcome | One of the following 3 elements should be covered: efficiency, quality of care, and accessibility. Articles that only include employment conditions are not taken into consideration. |
| Study design | Empirical research, no descriptive papers or economic modeling are included. |
Quality appraisal form
| Component Ratings of Study: | Score | Justification/Comments |
|---|---|---|
| Strong = 3/Modest = 2/Weak = 1 | ||
|
| ||
| Outcome of interest as main (3) or control variable (2/1)? | ||
| Cross‐sectional (2/1) or longitudinal (3) | ||
| Prospective (3) or retrospective (2/1) | ||
| Is the method of analysis appropriate? (strong, modest, weak) | ||
| Is the method of analysis sufficiently rigorous? (strong, modest, weak) | ||
|
| ||
| Enough data have been presented to show how the authors arrived at their findings (Strong, Modest, Weak) | ||
| Enough information is given what the methodological design is? (Strong, Modest, Weak) | ||
| Enough information is given where the data comes from and what the characteristics are of the sample (ie, summary statistics and sample sizes). (Strong, Modest, Weak) | ||
|
| ||
| Strong: The selected individuals/hospitals are very likely to be representative of the target population | ||
| Moderate: The selected individuals/hospitals are at least somewhat likely to be representative of the target population | ||
| Weak: The selected individuals/hospitals are not likely to be representative of the target population | ||
|
| ||
| Strong: will be assigned to those articles that controlled for most relevant confounders | ||
| Moderate: will be given to those studies that controlled for relevant confounders, but explicitly mentions that it missed some relevant confounders | ||
| Weak: will be assigned when the relevant confounders were not controlled for | ||
|
| ||
| Strong: The data collection tools have been shown to be valid; and the data collection tools have been shown to be reliable | ||
| Moderate: The data collection tools have been shown to be valid; and the data collection tools have not been shown to be reliable or reliability is not described. | ||
| Weak: The data collection tools have not been shown to be valid or both reliability and validity are not described. | ||
|
| ||
|
| ||
| Strong: Clear connection with 1 of the 3 concepts, and/or is generally accepted by scholars | ||
| Moderate: A couple of validity issues arise. The connection between the outcome variable and the concepts of interest is moderate (eg, only one disease is analyzed) | ||
| Weak: Serious concerns about how the outcome variable (1 of the 3 concepts) is measured | ||
|
| ||
| Strong: More than 10 hospitals are included in the analysis | ||
| Moderate: Between 3 and 10 hospitals are included in the analysis | ||
| Weak: Only 2 hospitals are compared | ||
|
| ||
| Strong: Includes many different contexts/regions, high complexity in demographic characteristics | ||
| Moderate: Combines 2 or 3 different regions | ||
| Weak: One very specific region with specific characteristics | ||
|
| ||
| Is this an independent study? Yes (3) Debatable (2) No (1) | ||
|
| ||
| Strong: (If applicable: will be assigned when the follow‐up rate is 80% or greater). | ||
| Moderate (If applicable: will be assigned when the follow‐up rate is 60%‐79%). | ||
| Weak: (If applicable: will be assigned when a follow‐up rate is less than 60% or if the withdrawals and drop‐outs were not described). | ||
| Total score | ||
|
|
| |
| Do the results seem to be valid? | ||
| Do the results seem to be reliable? | ||
| Are the results relevant? Does it fall within the scope of our research question? | ||
| Can the results be generalized? | ||
| In or out | If needed: justification | |
| Final judgment made based on the score and the additional comments | ||
Excluded references in quality appraisal
|
Browne, J., L. Jamieson, J. Lewsey, J. van der Meulen, L. Copley and N. Black (2008). “Case‐mix & patients' reports of outcome in Independent Sector Treatment Centres: comparison with NHS providers.” |
Summary of findings table (alphabetic order)
| Indicator | Methodology | Reliability Results | Generalizability Results | Year(s) Covered | Type (Private) | Country | |
|---|---|---|---|---|---|---|---|
|
| |||||||
| Barbetta et al | Technical | COLS, SFA, and DEA | Strong | Strong | 1995‐2000 | NFP | Italy |
| Barros et al | Cost | SFA | Moderate | Moderate | 1997‐2008 | NS | Portugal |
| Czypionka et al | Technical | Two‐stage DEA | Strong | Strong | 2010 | NFP | Austria |
| Daidone and D'Amico | Technical | SFA | Strong | Moderate | 2000‐2005 | FP + NFP | Italy |
| Gigantesco et al | LOS | Logistic regression | Weak | Strong | 2002‐2003 | Psych. | Italy |
| Tiemann and Schreyogg | Technical | Two‐stage DEA and Diff‐in‐Diff | Strong | Strong | 1996‐2008 | FP + NFP | Germany |
| Heimeshoff, Schreyögg, and Tiemann | Employment reduction | Diff‐in‐Diff and FE | Strong | Strong | 1996‐2008 | FP + NFP | Germany |
| Herr | Technical and cost | SFA | Strong | Strong | 2000‐2003 | FP + NFP | Germany |
| Herr, Schmitz, and Augurzky | Technical, cost and profit | SFA | Strong | Strong | 2002‐2006 | FP | Germany |
| Herwartz and Strumann | Technical | Two‐stage DEA + SFA | Strong | Strong | 1995‐2008 | FP + NFP | Germany |
| Lindlbauer and Schreyögg | Technical | Two‐stage DEA and SFA | Strong | Strong | 2000‐2010 | FP + NFP | Germany |
| Maravic and Landais | LOS | Linear multiple regression | Weak | Weak | 2001 | NS | France |
|
Schwierz | Responsiveness to demand changes | IVs + FE | Strong | Strong | 1996‐2006 | FP + NFP | Germany |
| Siciliani et al | LOS | Quantile regression | Moderate | Weak | 2006‐2007 | NS | United Kingdom |
| Sommersguter‐Reichmann and Stepan | Technical | Super efficiency DEA | Strong | Strong | 2009‐2012 | NFP | Austria |
| Vittadini et al | Upcoding (by the LOS) | Diff‐in‐Diff and FE | Strong | Moderate | 2007‐2008 | FP + NFP | Italy |
|
| |||||||
| Barbiere et al | Utilization by socioeconomic status | Multivariate logistic regression | Moderate | Weak | 1998‐2006 | ISTC | United Kingdom |
|
Biro and Hellowell | Waiting times | Region fixed effects | Moderate | Strong | 2000‐2001 & 2008‐2009 | ISTC | United Kingdom |
| Bonastre et al | Mean expenditure and usage chemotherapy | Multilevel analysis | Strong | Strong | 2008 | FP | France |
| Gusmano et al | Avoidable hospitalization | Multilevel analysis | Strong | Strong | 2004‐2008 | NS | France |
| Mason et al | Patient complexity | Mean difference by HRG | Moderate | Low | 2005‐2006 & 2006‐2007 | ISTC | United Kingdom |
| Pappa et al | Utilization by socio economic status | Multivariate logistic | Moderate | Low | 2003 | NS | Greece |
| Preti et al | Admission after suicide | Multivariate logistic | Moderate | Low | 2004 | Psych. | Italy |
| Riffaut et al | Access to preemptive registration on the waiting list | Multilevel analysis | Strong | Low | 2008‐2012 | FP | France |
| Río et al | Utilization by socioeconomic status | Logistic regression | Low | Moderate | 2005‐2006 | NS | Spain |
| Salvador et al ( | Utilization by socioeconomic status | Logistic regression | Low | Low | 1993‐2003 | NS | Spain |
| Siskou et al | Utilization by socioeconomic status and rural versus urban citizens | Stratified survey‐logistic regression | Low | Moderate | 2005 | NS | Greece |
| Souliotis et al | Utilization by socioeconomic and out‐of‐pocket payment | Descriptive statistics based upon a stratified sample | Weak | Moderate | 2011‐2012 | NS | Greece |
| Tountas et al | Utilization by socioeconomic status | Multivariate logistic analysis | Weak | Moderate | 2006 | NS | Greece |
|
| |||||||
| Berta et al | Mortality rate | Multilevel | Strong | Weak | 2009 | NFP | Italy |
| Britto‐Arias et al | Adherence guideline in colorectal cancer screening | Cohort study, relative frequencies with confidence intervals | Weak | Moderate | 2007‐2013 | NS | Austria |
| Gobillon and Milcent | Mortality rate | Survival analysis: cox model | Strong | Moderate | 1998‐2003 | FP | France |
| Gusmano et al | Rehospitalization rates | Step by step regression models | Moderate | Moderate | 2010 | NS | France |
| Louis et al | Inappropriate medical admissions | Descriptive statistics | Weak | Weak | 2001‐2005 | NS | Italy |
| Moscone et al | Readmission and death within 30 days | Multivariate OLS regression | Moderate | Weak | 2005‐2007 | NS | Italy |
| Owusu‐Frimponget al | Patient satisfaction on accessibility | Mixed method: semistructured interviews + cross‐sectional survey using ANOVA | Weak | Weak | X | NS | United Kingdom |
| Pérotin et al | Patients experience | Two‐stage switching regression model (incl. fixed effects) | Strong | Moderate | 2007‐2008 | ISTC | United Kingdom |
| Quercioli, Messina, Basu, McKee, Nante, and Stuckler | Avoidable mortality | Region‐specific fixed effects | Strong | Strong | 1993‐2003 | NS | Italy |
| Stroffolini et al | Compliance to the antenatal hepatitis B screening program | Multivariate logistic regression based upon a survey | Weak | Weak | 2001 | NS | Italy |
|
| |||||||
| Preti et al | Characteristics of patients, patterns of care, and discharges | Chi‐square or Fischer exact test | Weak | Weak | Data collection 2001‐2005 | Psych. | Italy |
| Berta et al | Cream skimming, readmission technical efficiency | SFA | Moderate | Strong | 1998‐2007 | FP + NFP | Italy |
| Fattore et al | Regional physical mobility, LOS | Logistic regression + multilevel | Strong | Strong | 2009 | NS | Italy |
| Kondilis et al | Bed capacity, occupancy rate, nursing staff rate, LOS, and payment per discharge | Confidence interval analysis | Weak | Moderate | 2001‐2003 | FP | Spain |
| Street et al | Patients from deprived versus affluent regions, LOS | Within‐HRG differences with | Weak | Weak | 2006/2007 | ISTC | United Kingdom |
| Tiemann and Schreyogg | Technical and controlled for mortality | Two‐stage DEA | Strong | Strong | 2002‐2006 | FP + NFP | Germany |
Abbreviations: ANOVA, analysis of variance; COLS, corrected ordinary least squares; DEA, data envelopment analysis; Diff‐in‐Diff, difference‐in‐difference; FE, fixed effect; FP, for‐profit; HRG, Healthcare Resource Groups; ISTC, independent sector treatment centers; IVs, instrumental variables; LOS, length of stay; NFP, not‐for‐profit; NS, not specified; OLS, ordinary least squares; Psych., (private) psychiatric hospitals; SFA, stochastic frontier analysis.
Overview technical efficiency of private hospitals compared with public hospitals
| Less Efficient | No Difference | More Efficient | |
|---|---|---|---|
| FP |
|
|
|
| NFP |
|
|
|
Abbreviations: FP, for‐profit; NFP, not‐for‐profit.
Other efficiency measures
| Outcome/Indicator | Number of Studies | Type (Private) | Countries | Impact |
|---|---|---|---|---|
| LOS | 3 | Aortic valve substitution, hip and knee procedures in private hospitals or ISTCs | Italy, United Kingdom, France | Private hospitals have shorter LOS |
| 3 | Private (ie, psychiatric hospitals, mental health clinics) hospitals and specifically for knee procedures | Italy, Greece, France | Private hospitals have longer LOS | |
| 1 | ISTCs (for most diagnostic groups) | United Kingdom | No difference | |
| Responsiveness to demand | 1 | FP | Germany | Public hospitals are less responsive |
| Employment | 1 | NFP | Germany | No difference |
| 2 | FP | Germany, Greece | Lower staff rate | |
| Upcoding | 1 | NFP + FP | Italy | Public hospitals have less “upcoding” |
| 1 | NFP + FP | Italy | No difference |
Abbreviations: ISTCs, independent sector treatment centers; FP, for‐profit; LOS, length of stay; NFP, not‐for‐profit.
Accessibility indicators overview
| Concept | Number of Studies | Outcome/Indicator | Type (Private) | Countries | Impact |
|---|---|---|---|---|---|
| Affordable | 8 | SES of patients (eg, employment status, residents from deprived versus affluent region) | Private (ie, maternity, psychiatric), ISTCs | Italy, United Kingdom, Greece, Spain | Public hospitals perform better |
| 2 | Method of payment (ie, private health insurance and pay out‐of‐pocket) | Private | Greece | ||
| 1 | Payment per discharge | FP | Greece | ||
| Physical | 3 | Case‐mix differences (eg, cream skimming) | FP, ISTCs | Italy, UK | |
| 1 | Access to specialty care (ie, adjusted rates of revascularization) | Private | France | ||
| 1 | Admission pattern | Private psychiatric | Italy | ||
| 1 | Access to preemptive registration | FP | France | ||
| 1 | Regional physical mobility (number of nonresident patients in the region admitted) | Private | Italy |
Abbreviations: ISTCs, independent sector treatment centers; FP, for‐profit; SES, socioeconomic status.
Quality of care indicators overview
| Concept | Number of Studies | Outcome/Indicator | Type (Private) | Country | Impact |
|---|---|---|---|---|---|
| Structure | 1 | Discontinuity of care | Private psychiatric | Italy | Public hospitals perform better |
| 1 | Qualification staff | FP | Greece | ||
| Process | 2 | Adherence guideline and screening | Private | Austria and Italy | |
| 1 | Appropriate admission | Private | Italy | ||
| Outcome | 2 | Mortality rate (avoidable mortality) | FP, private | France, Italy | |
| 1 | Rehospitalization rates | Private | France |
Abbreviations: ISTCs, independent sector treatment centers; FP, for‐profit; NFP, not‐for‐profit.